271 related articles for article (PubMed ID: 30222140)
21. Defective CD8 Signaling Pathways Delay Rejection in Older Recipients.
Bedi DS; Krenzien F; Quante M; Uehara H; Edtinger K; Liu G; Denecke C; Jurisch A; Kim I; Li H; Yuan X; Ge X; ElKhal A; Tullius SG
Transplantation; 2016 Jan; 100(1):69-79. PubMed ID: 26356176
[TBL] [Abstract][Full Text] [Related]
22. Selective CD28 blockade attenuates CTLA-4-dependent CD8+ memory T cell effector function and prolongs graft survival.
Liu D; Badell IR; Ford ML
JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321374
[TBL] [Abstract][Full Text] [Related]
23. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW
J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407
[TBL] [Abstract][Full Text] [Related]
24. CD8α+ dendritic cell trans presentation of IL-15 to naive CD8+ T cells produces antigen-inexperienced T cells in the periphery with memory phenotype and function.
Sosinowski T; White JT; Cross EW; Haluszczak C; Marrack P; Gapin L; Kedl RM
J Immunol; 2013 Mar; 190(5):1936-47. PubMed ID: 23355737
[TBL] [Abstract][Full Text] [Related]
25. IL2Rβ-dependent signals drive terminal exhaustion and suppress memory development during chronic viral infection.
Beltra JC; Bourbonnais S; Bédard N; Charpentier T; Boulangé M; Michaud E; Boufaied I; Bruneau J; Shoukry NH; Lamarre A; Decaluwe H
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5444-53. PubMed ID: 27573835
[TBL] [Abstract][Full Text] [Related]
26. Effect of inflammation on costimulation blockade-resistant allograft rejection.
Habiro K; Shimmura H; Kobayashi S; Kotani M; Ishida Y; Tanabe K; Toma H; Abe R
Am J Transplant; 2005 Apr; 5(4 Pt 1):702-11. PubMed ID: 15760393
[TBL] [Abstract][Full Text] [Related]
27. IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses.
Coley SM; Ford ML; Hanna SC; Wagener ME; Kirk AD; Larsen CP
J Immunol; 2009 Jan; 182(1):225-33. PubMed ID: 19109153
[TBL] [Abstract][Full Text] [Related]
28. Interruption of OX40L signaling prevents costimulation blockade-resistant allograft rejection.
Kitchens WH; Dong Y; Mathews DV; Breeden CP; Strobert E; Fuentes ME; Larsen CP; Ford ML; Adams AB
JCI Insight; 2017 Mar; 2(5):e90317. PubMed ID: 28289708
[TBL] [Abstract][Full Text] [Related]
29. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
Sepulveda H; Cerwenka A; Morgan T; Dutton RW
J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
[TBL] [Abstract][Full Text] [Related]
30. STAT5 is critical to maintain effector CD8+ T cell responses.
Tripathi P; Kurtulus S; Wojciechowski S; Sholl A; Hoebe K; Morris SC; Finkelman FD; Grimes HL; Hildeman DA
J Immunol; 2010 Aug; 185(4):2116-24. PubMed ID: 20644163
[TBL] [Abstract][Full Text] [Related]
31. New insights in CD28-independent allograft rejection.
Habicht A; Najafian N; Yagita H; Sayegh MH; Clarkson MR
Am J Transplant; 2007 Aug; 7(8):1917-26. PubMed ID: 17617854
[TBL] [Abstract][Full Text] [Related]
32. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
[TBL] [Abstract][Full Text] [Related]
33. IL-15 induces alloreactive CD28(-) memory CD8 T cell proliferation and CTLA4-Ig resistant memory CD8 T cell activation.
Traitanon O; Gorbachev A; Bechtel JJ; Keslar KS; Baldwin WM; Poggio ED; Fairchild RL
Am J Transplant; 2014 Jun; 14(6):1277-89. PubMed ID: 24842641
[TBL] [Abstract][Full Text] [Related]
34. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
[TBL] [Abstract][Full Text] [Related]
35. CD8(+)IL-17(+) T Cells Mediate Neutrophilic Airway Obliteration in T-bet-Deficient Mouse Lung Allograft Recipients.
Lendermon EA; Dodd-o JM; Coon TA; Miller HL; Ganguly S; Popescu I; O'Donnell CP; Cardenes N; Levine M; Rojas M; Weathington NM; Zhao J; Zhao Y; McDyer JF
Am J Respir Cell Mol Biol; 2015 May; 52(5):622-33. PubMed ID: 25286244
[TBL] [Abstract][Full Text] [Related]
36. Evidence of a novel IL-2/15R beta-targeted cytokine involved in homeostatic proliferation of memory CD8+ T cells.
Kamimura D; Ueda N; Sawa Y; Hachida S; Atsumi T; Nakagawa T; Sawa S; Jin GH; Suzuki H; Ishihara K; Murakami M; Hirano T
J Immunol; 2004 Nov; 173(10):6041-9. PubMed ID: 15528339
[TBL] [Abstract][Full Text] [Related]
37. IL-15-induced CD8+CD122+ T cells increase antibacterial and anti-tumor immune responses: implications for immune function in aged mice.
Motegi A; Kinoshita M; Inatsu A; Habu Y; Saitoh D; Seki S
J Leukoc Biol; 2008 Oct; 84(4):1047-56. PubMed ID: 18653461
[TBL] [Abstract][Full Text] [Related]
38. Allograft dendritic cell p40 homodimers activate donor-reactive memory CD8+ T cells.
Tsuda H; Su CA; Tanaka T; Ayasoufi K; Min B; Valujskikh A; Fairchild RL
JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467328
[TBL] [Abstract][Full Text] [Related]
39. NK cells delay allograft rejection in lymphopenic hosts by downregulating the homeostatic proliferation of CD8+ T cells.
Zecher D; Li Q; Oberbarnscheidt MH; Demetris AJ; Shlomchik WD; Rothstein DM; Lakkis FG
J Immunol; 2010 Jun; 184(12):6649-57. PubMed ID: 20483732
[TBL] [Abstract][Full Text] [Related]
40. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes.
Ilangumaran S; Ramanathan S; La Rose J; Poussier P; Rottapel R
J Immunol; 2003 Sep; 171(5):2435-45. PubMed ID: 12928391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
